ArticleCancers2024

The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population.

Silvana A M Urru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.